clinical trial · NCT06512363
A Study of Ramelteon in Chinese Patients With Chronic Insomnia
Nanjing Chia-tai Tianqing Pharmaceutical·phase3·not yet recruiting·n = 280
Chronic InsomniaRamelteonRamelteon placebo
brief summary
The purpose of this study is to assess the efficacy and safety of Ramelteon in chinese patients with chronic insomnia. Efficacy will be evaluated on objective and subjective sleep parameters.
started
Aug 1, 2024
primary completion
Dec 1, 2026
completion
Dec 1, 2026
last updated
Jul 22, 2024
official title
A Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Phase 3 Clinical Study to Investigate the Efficacy and Safety of Ramelteon in Chinese Patients With Chronic Insomnia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol